Denise Neves Gameiro, Author at Labiotech.eu

About

Journalist intern. Studied Bioengineering in Porto and was a lab rat in Sweden. Enjoying Berlin and the company of Labiotech’s resident plants.

Articles by Denise Neves Gameiro

allecra forbion delos antibiotic resistance

News and Trends 16 Jun 2016

Novel Antibiotic for Resistant Bacteria gets a €22M Push from Key Investors

Allecra Therapeutics has raised €22M in its Series B round from some key investors. The money will back the Phase II trials for a new broad-spectrum antibiotic for resistant bacteria. The development of antibiotic resistance in bacteria has been one of the key concerns of healthcare authorities for quite some time. The World Health Organisation estimates […]

June 16, 2016 - 3 minutesmins - By Denise Neves Gameiro

indiebio eu 2016 synthetic biology accelerator

News and Trends 16 Jun 2016

Europe’s Leading SynBio Incubator has 13 new Biotechs ready to Hatch

IndieBio is an accelerator program for new ideas in Synthetic Biology. The participants of the most recent edition (Summer 2016) have been hard at work in Ireland since May 3rd – and now you can take a peek at what’s going on. The objective of IndieBio‘s program is to unlock the creative potential of students, researchers or […]

June 16, 2016 - 4 minutesmins - By Denise Neves Gameiro

eva daignostics startup battle labiotech refresh biotech

News and Trends 15 Jun 2016

Eva Diagnostics: “We identified the pain points of the Blood testing market” #LBRefresh

Eva Diagnostics was one of the contestants at our Startup Battle during Labiotech Refresh. Take a second look with us at the pitch of Eva’s exciting diagnostic Tech… We had Sabine Dziemian, the head of data analysis at Eva Diagnostics, explain how this spin-off out of Imperial College London is joining the race for MedTech diagnostics. […]

June 15, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 15 Jun 2016

Boosting a Single Protein makes for a 50% more Productive Rice

Researchers from the John Innes Centre and Nanjing Agricultural University have identified a protein that can help plants regulate their cell pH – a seemingly small modification that can boost rice crop yields by 50%. Rice is one of the major crops in the world, along with corn and wheat (also under the microscope of science […]

June 15, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 15 Jun 2016

Dutch Fund raises €250M to invest in Late Stage Biotechs

Gilde Healthcare has raised €250M for its 4th fund in an oversubscribed round. The money will go to late-stage MedTech, digital health and therapeutics, which can join a portfolio with some of the European celebrity-Biotechs. Gilde Healthcare is based in Utrecht (Netherlands) and Cambridge (Massachussets), investing in healthcare companies on both sides of the Atlantic. This VC […]

June 15, 2016 - 2 minutesmins - By Denise Neves Gameiro

ziarco atopic dermatitis psoriasis skin inflammation

News and Trends 14 Jun 2016

British Biotech startup shows 50% improvement in Atopic Dermatitis

Ziarco has received positive results from a Phase II trial with its leading candidate, which has shown to improve symptoms of atopic dermatitis by 50%, giving it the potential to fill the current need for a safe oral treatment for this inflammatory skin disease. Ziarco is a private biotech with a clinical-stage pipeline for inflammatory skin […]

June 14, 2016 - 2 minutesmins - By Denise Neves Gameiro

kings college depression biomarker diagnostic

News and Trends 14 Jun 2016

New Biomarkers could make Personalized Medicine for Depression

Researchers from King’s College London have succeeded in developing a blood test that can help choose the best treatment for depression patients – a big improvement over the current trial-and-error approach. Depression doesn’t seem to be a particularly popular indication for biotechs, unlike other nervous systems diseases that reached significant milestones in the last year. Moreover, one […]

June 14, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 13 Jun 2016

Italy cures Diabetes with new Engineered Mini-organs

Ospedale Niguarda Ca’ Granda has succeeded in treating a patient with type 1 diabetes, using a new tissue engineering techniques for more effective islet transplants – something that could bring this diabetes cure to more patients. Biotech is tackling diabetes from several fronts – from mitigation of symptoms, for example, Avita’s skin spray, to medtech inventions […]

June 13, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 13 Jun 2016

Immunotherapy reaches Breakthrough in eliminating HIV

Immunocore has published key results for its new preclinical candidate for HIV, ImmTAV. This TCR-based immunotherapy has succeeded in targeting T-cells where HIV infection often ‘hides’ from drugs. Just after presenting promising results from its leading candidate at ASCO 2016 (read our coverage here), Immunocore is making headlines in another area – infectious disease. The […]

June 13, 2016 - 3 minutesmins - By Denise Neves Gameiro

vaccination gates foundation vaccine delivery

News and Trends 10 Jun 2016

Gates Foundation is funding EU Biotech to make Vaccines more affordable

Batavia Biosciences has won a €3.3M grant from the Gates Foundation, to fund new research in making cell culture cheaper – and drive down the price of some key vaccines. Within its goal of pushing science forward and bringing to developing countries, the Gates Foundation has outlined vaccine delivery as a key part of its strategy. […]

June 10, 2016 - 3 minutesmins - By Denise Neves Gameiro

crispr therapeutics muscle stem cells anagenesis

News and Trends 10 Jun 2016

CRISPR Thx in yet another Collaboration, this time for Muscle Dystrophy

CRISPR Therapeutics has struck a deal with Anagenesis Biotechnologies, which has key technology for muscle stem cells. Together, they will tackle muscle disorders – including the rare disease Duchenne Muscular Dystrophy (DMD). CRISPR Therapeutics (Basel, Switzerland) is the European champion of gene editing for health applications, a field that promises to revolutionize therapies – even if […]

June 10, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 9 Jun 2016

German Biotech launches Phase II in a hot Target for Inflammation

InflaRx has treated the first patient in a new Phase II trial, which is studying the potential of its anti-complement antibody in avoiding immunological complications after complex cardiac surgery – a big unmet need. It is competing with world most expensive drug Soliris from Alexion (US). Based in Jena (Germany), InflaRx specializes in developing new […]

June 9, 2016 - 3 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Denise Neves Gameiro

About

Articles by Denise Neves Gameiro

Novel Antibiotic for Resistant Bacteria gets a €22M Push from Key Investors

Europe’s Leading SynBio Incubator has 13 new Biotechs ready to Hatch

Eva Diagnostics: “We identified the pain points of the Blood testing market” #LBRefresh

Boosting a Single Protein makes for a 50% more Productive Rice

Dutch Fund raises €250M to invest in Late Stage Biotechs

British Biotech startup shows 50% improvement in Atopic Dermatitis

New Biomarkers could make Personalized Medicine for Depression

Italy cures Diabetes with new Engineered Mini-organs

Immunotherapy reaches Breakthrough in eliminating HIV

Gates Foundation is funding EU Biotech to make Vaccines more affordable

CRISPR Thx in yet another Collaboration, this time for Muscle Dystrophy

German Biotech launches Phase II in a hot Target for Inflammation

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by Denise Neves Gameiro

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!